Remodulin

GPTKB entity

Statements (61)
Predicate Object
gptkbp:instance_of gptkb:drug
gptkbp:activities vasodilator
gptkbp:approves gptkb:2002
gptkbp:brand gptkb:Remodulin
gptkbp:class prostacyclin analog
gptkbp:clinical_trial studied in multiple clinical trials
chronic treatment
gptkbp:contraindication severe hepatic impairment
hypersensitivity to treprostinil
gptkbp:dosage_form solution for injection
gptkbp:duration long-term therapy
gptkbp:education storage instructions
recognizing side effects
importance of adherence
proper injection technique
when to seek medical help
gptkbp:effective_date FDA approved
gptkbp:formulation sterile solution
gptkbp:frequency continuous infusion
subcutaneous infusion every 24 hours
https://www.w3.org/2000/01/rdf-schema#label Remodulin
gptkbp:indication improving exercise ability
gptkbp:ingredients C20 H30 O5 S
treprostinil
gptkbp:interacts_with anticoagulants
antihypertensives
other vasodilators
gptkbp:is_available_on generic version
gptkbp:is_monitored_by blood pressure
heart rate
symptoms of pulmonary hypertension
gptkbp:is_used_for pulmonary arterial hypertension
gptkbp:lifespan approximately 4 hours
gptkbp:manager intravenous infusion
subcutaneous injection
gptkbp:manufacturer gptkb:United_Therapeutics_Corporation
gptkbp:marketed_as gptkb:legislation
gptkb:United_States
gptkb:Native_American_tribe
gptkbp:packaging vials
gptkbp:pharmacokinetics metabolized in the liver
increases blood flow
gptkbp:population adults and children
gptkbp:safety_features generally well tolerated
gptkbp:side_effect gptkb:fandom
dizziness
headache
nausea
vomiting
diarrhea
thrombocytopenia
hypotension
palpitations
jaw pain
flushing
injection site reaction
gptkbp:storage refrigerated
gptkbp:type_of_care important for efficacy
gptkbp:bfsParent gptkb:Treprostinil
gptkb:United_Therapeutics_Corporation
gptkbp:bfsLayer 6